How Should Newly Approved Drugs Be Used in Practice?
Your source for worldwide news and
perspectives on hematology/oncology
volume 04 | number 02
january 2018 annual meeting edition
CONTENTS
Letters to the Editor
The CRO Agony
Continues …
Written in Blood
Can Transfusions
Protect Against Stroke
in Patients With SCD?
Blood Advances in a Different Vein
Patients With Myeloma
at Risk for Second
Cancers
On Location
Frontline Bleomycin
or Brentuximab for
Hodgkin Lymphoma?
Advancing CAR T-Cell
Therapy for Myeloma
Evaluating the First Anti-
Sickling Agent for SCD
Highlights from the 2017
ASH ANNUAL MEETING
NEW DRUGS, NEW INDICATIONS, AND NEW INSIGHTS FROM THE
WORLD’S MOST COMPREHENSIVE HEMATOLOGY EVENT
DEPARTMENTS
14 UP FRONT
15 CLINICAL NEWS
35 BACK OF THE BOOK
www.ASHClinicalNews.org
The Society Pages:
Recent Promotions
and Transitions
Latest & Greatest:
New and Noteworthy
Research
Data Stream:
Health-Care Facts
& Figures